1Selivin E,Bolen S,Hsin-Chieh Yeh HC,et al.Cardiovascular outcomes in trails of oral diabetes medication:Asystematic review[].Archives of Internal Medicine.2008
2Jarris S.Rosiglitazone and pioglitazone:Where do we go from here[].Br Cardiol.2008
3Hazama Y,Matsuhisa M,Ohtoshi K,et al.Beneficial effects of nateglinide on insulin resistance in type2diabetes[].Diabetes Research and Clinical Practice.2006
4Eurich DT,Majumdar SR,McAlister FA,et al.Improved clinical out-comes associated with metformin in patients with diabetes and heart failure[].Diabetes Care.2005
5Rosenthal JH,Mauersberger H.Effects on blood pressure of the alpha-glucosidase inhibitor acarbose compared with the insulin enhancer glibenclamide in patients with hypertension and type2diabetes mellitus[].Clinical Drug Investigation.2002
6Kahn SE,Zinman B,Lachin JM, et al.Rosiglitazone-asso- ciated fractures in type 2 diabetes: an Analysis from A Dia- betes Outcome Progression Trial (ADOPT)[].Diabetes Care.2008
